Digital Transformation Bayer is transforming into a "cool company"

Pharmaceutical sonmay 29 (Xinhua) -- Bayer announced a commercial partnership with WaveForm in BeijingAccording to the company's press release, the partnership "combines WaveForm's innovative know-how and Bayer's extensive experience and expertise in diabetes management to bring innovative dynamic blood glucose monitoring solutions to Chinese patients and doctors." "
outside the circle readers may have taken the news by the same as it didBut industry insiders familiar withmedicinecirclehaved a different story: the century-old drug company is turning into a "cool company"Together with the global science "net red"Bayer signed a global technology "net red"The company, whose full name is WaveForm Technologies Inc., has been developing new dynamic glucose monitoring (CGM) productsProducts currently under development include innovative dynamic blood glucose monitoring sensor technology, related firmware, software and data storage platformsWaveForm has also developed a proprietary "closed-loop" insulin delivery platform designed to provide a complete solution for people with diabetesWaveForm's parent company, Aga Matrix, is even more promisingBack in 2011, it released the world's first iPhone-enabled iBG Star, agaMatrix, even before the iPhone was replaced with the lightning data interfaceThis time Bayer and WaveForm are contracting to launch a dynamic blood glucose monitoring solution in Chinese mainland, WaveForm's CGM system, a patented innovation based on a number of glucose sensor technologiesIn the words of John Alberico, CEO of AgaMatrix Holdings Limited, the device is characterized by the following characteristics for patients:- this is a painless implanted product that sustains the monitoring of glucose levels in tissue fluid - longer wearing time: The device can be worn up to 15 days - Alert: Comprehensive CGM capabilities provide real-time data and alert - minute monitoring: sensors and re-used transmitters are transmitted to the mobile application for accurate measurements of blood sugar per minute through Bluetooth ® Users can easily view the latest blood sugar readings within a minute on their smartphones 　　For doctors, perhaps in the near future, the ability to continuously and comprehensively track a patient's blood sugar levels by collecting data from a patient's dynamic blood glucose monitoring via a smartphone can provide valuable information for evaluating and guiding diabetes treatment, and even remote diagnosis 　　Provides precision "personalization" services in the field of diabetes
according to the latest data released by the International Diabetes Alliance, about 116 million adults in China have diabetes and more than 65 million undiagnosed In a separate study published in the Journal of the American Medical Association, only 32.2 percent of all people with diabetes in China received treatment, and only 49.2 percent of them had effective blood sugar control Therefore, this upcoming dynamic blood glucose monitoring program for the "big country of diabetes", can be described as very timely, very cool 　　Under the agreement, WaveForm will be responsible for obtaining the listing of its Cascade CGM system in Chinese mainland and for post-market maintenance, while Bayer will be responsible for the commercialization, distribution and sale of the system in Chinese mainland, as well as customer support Bayer and WaveForm will also explore customized upgrades to CGM products for the needs of Chinese patients and doctors 　　It is well known that Bayer has been in the field of diabetes for many years, with extensive experience and product portfolio, not only to help diabetics improve treatment outcomes, effectively manage complications, improve quality of life, but also help people with prediabetes (IGT) to delay the development of diabetes 　　"Early monitoring and detection are prerequisites for prevention and treatment," said David Jiang, Global Executive Vice President of the Prescription Drug Division of the Bayer Group and President of China and Asia Pacific, and President of Bayer Group Greater China Bayer hopes to bring convenient and efficient blood glucose monitoring to Chinese patients and the public through its expertise in effective treatment of diabetes, combined with WaveForm's innovative technology "
Bayer ready to digital "transformation" the industry's feelings about Bayer, are recognized as a German-born, established company, more than 150 years of history, heavy-duty drugs aspirin, Baitang, such as the h-H Low-key, down-to-earth has always been its main theme 　　But in fact, the established company is taking a step at a time to achieve its digital "transformation" At the head office group level, Bayer is digitizing the core value chain of each division, Health
Consumer Products, Crop Science, and Prescription Drugs, including the development and marketing of product supply, and the integration of artificial intelligence and data science into the transformation process 　　In the field of prescription drugs, using analytics and digitalization to accelerate drug development and improve the quality, cost and cycle of drug development is also one of Bayer's goals For example, with devices such as wearable devices and sensors, patients can more easily participate in clinical trials, and medical workers and pharmaceutical companies can collect and process actual data more efficiently and quickly, greatly reducing the time of clinical trials and more accurately predicting real patient conditions 　　According to Abel Archundia-Pineda, global head of IT and digital transformation at Bayer's prescription drug division, digital transformation will enable companies to deliver new drugs to patients faster, personalize treatments, improve the efficiency of healthcare, and ultimately make the healthcare system better for patients 　　China is a focus of Bayer's cooperation digital transformation, and the Chinese market is a top priority for Bayer This also explains why Bayer's commercial partnership with WaveForm was launched in Beijing 　　"It's a very important strategic initiative for the company to work with such a great partner as WaveForm Dr Marianne De Backer, Head of Global Business Development, Bayer's Prescription Drug Division, said in particular, "Bayer wants to turn innovation into a solution that makes sense for our patients, and China is our focus, and we are constantly looking for partners in digital technology development." "
in fact, Bayer has long targeted its cooperation with its digitally promising Chinese start-up enterprises through its annual Startup Program, G4A China Over the past three years, 11 enterprises and projects have been selected in China through this entrepreneurship accelerator, including hospitals smart medicine boxes, computer-aided diagnostic systems based on medical images, etc These stand-out companies have been at Bayer's headquarters for close and in-depth exchanges with Bayer's various affairs departments, some of which have established long-term relationships with Bayer 　　From Start-up - G4A China to join-in waveForm, from headquarters to China, Bayer, a century-old pharmaceutical company, is ready to "transform" Jiang Wei said at the JP Morgan Conference in early 2020: Bayer wins the future, only innovation and cooperation "The necessary condition for success is that the first thing for an enterprise to have innovative products as a basis Second, cross-border, cross-company cooperation is another key factor for future success "